ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer, AIDS Drug Screening Contracts Ok’d For Recompetition

February 28, 1992

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

NCAB Subcommittee Tells Califano To Keep Hands Off Board Appointments

May 18, 1979

NCI Internal Debate Ends With Move of Biometry Branch, Including SEER, From DCCP To DRCCA

September 23, 1983

ASCO Endorses Guideline for Molecular Testing

October 17, 2014